The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.
Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S; EANM Neuroimaging Committee.
Garibotto V, et al. Among authors: lammerstma aa.
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y.
Eur J Nucl Med Mol Imaging. 2021.
PMID: 34272989
No abstract available.